knowledge -WSS

knowledge

author：knowledge 2025-09-06 03:55:09 - browse：212

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Winning ticket for $1 billion Powerball jackpot sold in California

leisure time

WSS

Insmed lung disease drug hits target in key Phase 3 trial

iTeos Therapeutics debuts first data on TIGIT

Addiction doctors spar with methadone clinics over legislation

AI used to predict Covid

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

In Memoriam: Notable people who died in 2023

Stigma and the return of syphilis

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

First Opinion Podcast: What happens when kids become caregivers?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Winning ticket for $1 billion Powerball jackpot sold in California

Hollywood unions extend contract negotiations for actors

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Wikipedia

Tesla recalling nearly 16,000 of its 2021

Akili, maker of video game for ADHD, to be acquired for 34 million

Tocagen's brain cancer gene therapy trial continues. Investors worry

Health insurers say they are turning to AI to cut costs, improve care

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

DeSantis talks Trump, trans issues and 'what wokeness is'

entertainment

explore

leisure time

focus